Edition:
United States

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

7.56USD
27 Sep 2016
Change (% chg)

$0.09 (+1.20%)
Prev Close
$7.47
Open
$7.45
Day's High
$7.63
Day's Low
$7.45
Volume
9,932
Avg. Vol
46,892
52-wk High
$10.16
52-wk Low
$2.63

MNOV.OQ

Chart for MNOV.OQ

About

MediciNova, Inc. is a biopharmaceutical company. The Company is focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) for neurological... (more)
No analyst recommendations are available for MNOV.OQ.

Overall

Beta: 0.79
Market Cap(Mil.): ¥24,714.61
Shares Outstanding(Mil.): 34.47
Dividend: --
Yield (%): --

Financials

  MNOV.OQ Industry Sector
P/E (TTM): -- 42.41 36.20
EPS (TTM): -36.40 -- --
ROI: -- -0.33 13.87
ROE: -- -3.14 14.78

BRIEF-MediciNova sees loss per share for year ending Dec 31 of $0.31

* Says expected loss per share for year ending December 31, 2016 is $0.31

Jul 27 2016

BRIEF-MediciNova receives notice of allowance for new patent covering MN-001 and MN-002 for the treatment of fibrosis

* Says it received a notice of allowance from the U.S. Patent And Trademark Office (Uspto) for a pending patent application which covers Mn-001 (Tipelukast) and Mn-002 (A Major Metabolite Of Mn-001) for the treatment of "Fibrosis" which includes a broad range of fibrosis / fibrotic disease in different organs due to different causes

Jul 26 2016

BRIEF-Medicinova starts interim efficacy analysis in phase 2b trial of MN-166

* Medicinova announces initiation of interim efficacy analysis in phase 2b trial of MN-166 (ibudilast) in progressive MS

Jul 13 2016

BRIEF-Medicinova added to Russell 3000  Index and Russell Global Index

* Company has been added to Russell 3000  Index and Russell Global Index as a result of annual Russell Index reconstitution

Jun 26 2016

BRIEF-MediciNova to offer off-floor distribution of 800,000 shares

* Says it to offer an off-floor distribution of 800,000 shares of its stock at the price of 644 yen per share, on the Tokyo Stock Exchange on May 17

May 16 2016

BRIEF-MediciNova to offer off-floor distribution of shares

* Says it to offer an off-floor distribution of 800,000 shares on Tokyo Stock Exchange between May 17 and May 19

May 10 2016

BRIEF-Medicinova appoints Ryan Selhorn as CFO

* Appointed Ryan Selhorn of accounting services firm of Signature Analytics San Diego to serve as CFO

Mar 31 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.